GLAXF – Invest Smart Edge

AAPL | AAPL:CA | ABT | ADBE | ADBE:CA | AMZN | AMZN:CA | ASR | ASRMF | BABA | BABAF | Fund Letters | Generation PMCA Corp | GLAXF | GOOG | GOOG:CA | GOOGL | GSK | LULU | LULU:CA | MCD | MCDS:CA | MRVL | MSFT | MSFT:CA | PAX | SBUX | SBUX:CA | SP500 | SPX | SURRF | SURRY | UBER | UBER:CA | UNH | UNH:CA | US10Y

Generation PMCA Q1 2025 Quarterly

ByMario Cazombo May 30, 2025

CHD | CL | CLX | ENR | GLAXF | GSK | JNJ | KMB | MMM | Paul Franke | PG | REYN | SPB

Procter & Gamble: 3.7% Free Cash Flow Yield Is Not Good Enough

ByMario Cazombo May 28, 2025

ALLKA Research | ALPMF | ALPMY | BMY | BMYMP | CELG.RT | DSKYF | DSNKY | GLAXF | GSK | MRK | MRK:CA | PFE | PFE:CA | SPY

Merck Proves Why It’s Still A Top Pharma Pick

ByMario Cazombo May 27, 2025

BABA | BABAF | CAIXY | CIXPF | GLAXF | GSK | ING | ISG | JSNSF | Mutual Fund Commentaries | OTPGF | Pzena Investment Management | SCBFF | TTDKF

Pzena International Value ADR Q1 2025 Commentary

ByMario Cazombo May 27, 2025

ALLKA Research | AZN | AZNCF | BEIGF | BMY | BMYMP | CELG.RT | GILD | GILD:CA | GLAXF | GNFT | GNFTF | GSK | IPSEF | IPSEY | JNJ | JNJ:CA | MRK | MRK:CA | ONC

Gilead Sciences’ Best Days May Be Ahead – Here’s Why

ByMario Cazombo May 26, 2025